Incidence of frailty: a systematic review of scientific literature from a public health perspective by Galluzzo, Lucia et al.
M
o
n
o
g
r
a
p
h
ic
 s
e
c
t
io
n
239
Incidence of frailty: a systematic 
review of scientific literature 
from a public health perspective 
Lucia Galluzzo1, Rónán O’Caoimh2, Ángel Rodríguez-Laso3, Nathalie Beltzer4,  
Anette Hylen Ranhoff5, Johan Van der Heyden6, Maria Lamprini-Koula7, Marius Ciutan8, 
Luz López- Samaniego9 and Aaron Liew2 on behalf of Work Package 5 of the Joint Action 
ADVANTAGE
1Dipartimento Malattie Cardiovascolari, Dismetaboliche e Invecchiamento, Istituto Superiore di Sanità, 
Rome, Italy 
2Health Service Executive of Ireland (Social Care Division) and National University of Ireland (Discipline  
of Medicine), Galway, Ireland 
3Fundación para la Investigación Biomédica del Hospital Universitario de Getafe, Getafe, Spain  
4Santé Publique, Saint Maurice, France  
5Nasjonalt Folkehelseinstitutt (Norwegian Institute of Public Health), Oslo, Norway 
6Sciensano, Brussels, Belgium 
7Society of Psychosocial Research and Intervention, Ionnina, Greece 
8Scoala Nationala de Sanatate Publica, Management si Perfectionare in Domeniul Sanitar, Bucharest,  
Romania 
9 Fundación Progreso y Salud, Consejeria de Salud de la Junta de Andalucia, Sevilla, Spain
Ann Ist Super Sanità 2018 | Vol. 54, No. 3: 239-245
DOI: 10.4415/ANN_18_03_11
INTRODUCTION
The scientific and public health importance of frailty 
has become increasingly relevant over the past decades. 
Frailty is now considered one of the major challenges of 
global population aging, causing suffering and harm to 
individuals and their families, and threatening the long-
term sustainability of current health care systems [1-3].
Much effort has been made to reach a clear defini-
tion of frailty and to understand both its aetiology and 
the potential for prevention. A common classification 
for research and clinical practice is yet to be achieved 
[4] but the conceptual and theoretical bases of frailty 
as a syndrome are well established [3, 5, 6]. One of the 
major achievements of recent research is the increased 
recognition that frailty is not part of the natural aging 
process. It is distinct from disability or multi-morbidity, 
although strictly related to them, and it is a complex, 
multifaceted, dynamic process [7]. 
In 2015, the World Health Organization summa-
rized the background knowledge on frailty defining it 
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Abstract
Introduction. Because of the dynamic nature of frailty, prospective epidemiological data 
are essential to calibrate an adequate public health response.
Methods. A systematic review of literature on frailty incidence was conducted within the 
European Joint Action ADVANTAGE.
Results. Of the 6 studies included, only 3 were specifically aimed at estimating frailty 
incidence, and only 2 provided disaggregated results by at least gender. The mean follow-
up length (1-22.2 years; median 5.1), sample size (74-6306 individuals), and age of par-
ticipants (≥ 30-65) varied greatly across studies. The adoption of incidence proportions 
rather than rates further limited comparability of results. After removing one outlier, 
incidence ranged from 5% (follow-up 22.2 years; age ≥ 30) to 13% (follow-up 1 year, age 
≥ 55).
Conclusions. Well-designed prospective studies of frailty are necessary. To facilitate 
comparison across studies and over time, incidence should be estimated in person-time 
rate. Analyses of factors associated with the development of frailty are needed to identify 
high-risk groups.
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as a “progressive age-related decline in physiological 
systems that results in decreased reserves of intrinsic 
capacity, which confers extreme vulnerability to stress-
ors and increases the risk of a range of adverse health 
outcomes” [8]. The adverse outcomes related to frailty 
include disability, falls, hospitalization, and mortality 
[9]. Since frailty is a dynamic condition along a con-
tinuum from normal aging to disability, during which 
transitions between frailty states are common, and re-
covery, although not frequent, is possible [10, 11], there 
is ample potential for prevention aimed at maintaining 
homeostasis and limiting the vulnerability to endoge-
nous and exogenous stressors that lead to the adverse 
health related outcomes [1, 2, 9, 12].
The European Union met this public health challenge 
by supporting and co-financing the Joint Action (JA) 
ADVANTAGE “A comprehensive approach to promote 
a disability-free advanced age” in the framework of the 
Third Programme of Community Action in the field of 
Health. Its aim is to mobilize Member States (MS) to 
cooperate and work towards the uptake, exchange and 
development of a common approach to frailty preven-
tion and management. ADVANTAGE is a 3-year Joint 
Action (2017-2019) involving 22 MSs, represented 
by 33 organizations. The project is structured around 
eight work packages. One of them has the specific ob-
jective of exploring the current state of knowledge on 
the epidemiology of frailty, analysing available data on 
prevalence, incidence, and transitions between discrete 
frailty states [13].
Understanding the real burden of frailty, its charac-
teristics and progression in the population is essential 
to calibrate an adequate public health response, balanc-
ing available resources against individual and collective 
needs. Detailed and reliable epidemiological findings 
are necessary to inform resource planning, prioritisa-
tion of interventions addressed to groups of people at 
higher risk, and to evaluate the effectiveness of preven-
tion programmes. Current epidemiological evidence on 
frailty usually focuses on prevalence and little is known 
on the prospective aspects of frailty in the population. 
The purpose of the present study was to carry out a sys-
tematic review of literature on the incidence of frailty, 
with a special focus on the public health implications of 
retrieved results. 
MATERIALS AND METHODS
Data sources and search strategy
As part of the European JA ADVANTAGE [14] on 
prevention and management of frailty, a systematic 
search of published and unpublished studies concern-
ing the frequency of frailty in the general population 
was carried out using two parallel approaches. First, 
we searched for scientific literature using PubMed, 
Embase, CINAHL, MEDLINE, Opengrey and the 
Cochrane Library databases. Second, an opportunistic 
search for unpublished data was conducted among the 
JA partners, asking them for research projects ongoing 
in their own countries that explicitly addressed the epi-
demiology of frailty. 
For practical purposes and to minimize oversight and 
inadvertent omissions, the search for relevant articles 
was not limited to incidence but extended to prevalence, 
as prevalence studies on frailty, which are far more com-
mon, may also include information on incidence. The 
following search query was adopted: [(“Elderly” OR 
“Aged” OR “Older adult$” OR “Older person$” OR 
“Geriatric$”) AND (“Frailty” OR “Frail”) AND (“Pop-
ulation-based” OR “Population based”) AND (“Preva-
lence” OR “Incidence”, OR” Epidemiology”) NOT 
Search # (“Frailty model” OR “Frailty survival model”)]. 
Results relating to frailty incidence were then singled 
out and presented in the present paper, whereas find-
ings concerning the prevalence of frailty are reported in 
another paper of the present journal issue [15].
The review was carried out in accordance with the 
Preferred Reporting Items for Systematic Reviews and 
Meta-Analyses (PRISMA) guidelines [16]. The adopt-
ed protocol was registered on the international prospec-
tive register of systematic reviews PROSPERO (Uni-
versity of York, Centre for Reviews and Dissemination; 
Reference number CRD42017071866) [17]. 
Inclusion criteria
Papers were included if they explicitly addressed 
frailty, irrespective of the definition or diagnostic instru-
ment used. As a rough guide to reviewers, in order to 
discriminate between pertinent/irrelevant papers, frailty 
was defined as a state of increased vulnerability to en-
dogenous and exogenous stressors that exposes the in-
dividual to a higher risk of negative health-related out-
comes [3]. Incidence was defined as the number of new 
cases of frailty per population in a given time period.
All studies published from January 2002 to April 
2017, with participants aged 18 or more (no maximum 
age limit), in English or any other language of JA part-
ners were eligible for inclusion in the systematic review. 
The reference sections of papers meeting the inclusion 
criteria were manually examined to find additional ar-
ticles not identified through the database searches. Pa-
pers published before 2002 were included if deemed 
relevant to the review. 
Original papers reporting studies conducted either 
on community dwelling or hospitalized/institutional-
ized participants (regardless of the reasons of admis-
sion) were eligible, provided that the findings could be 
extended to the general population, and not restricted 
to a segment affected by particular diseases or condi-
tions. Other reasons for exclusion were: replicated data, 
Randomized Controlled Trials, letters to the editor, ab-
stract only publications, conference proceedings, non-
systematic reviews, and editorials. 
Data selection and analysis 
The screening of abstracts was conducted indepen-
dently by two reviewers. The full text of papers se-
lected as potentially relevant by one or both of them 
was retrieved for in-depth evaluation. Disagreements 
were settled by a third reviewer. Data from articles as-
sessed as eligible for inclusion in the systematic review 
were extracted and analysed by expert reviewers. Data 
extraction from articles written in languages different 
from English was done by a native speaker from a JA 
partner country.
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Due to the limited number and heterogeneous char-
acteristics of the available literature, data obtained 
through the systematic search were not pooled or meta-
analysed to produce an overall quantitative estimate, 
but synthesized and compared using a narrative and 
tabular approach [18].
The methodological quality of selected papers was as-
sessed by two independent critical appraisers using the 
Joanna Briggs Institute (JBI) critical assessment tool for 
prevalence and incidence studies [19]. Discrepancies in 
the evaluation were discussed and resolved through con-
sensus. The quality appraisal was not merely aimed to as-
sign a score for inclusion/exclusion of papers, but to ascer-
tain the extent to which the possibility of bias in the study 
design, conduction and analysis had been addressed. The 
results of the evaluation were incorporated in the synthe-
sis and interpretation of the systematic review results.  
RESULTS
We found 2948 papers on prevalence and/or incidence 
of frailty through the literature search. Twenty-nine ad-
ditional records, 6 of them potentially relevant only for 
incidence, were identified by reading references of se-
lected papers. The opportunistic search for unpublished 
data provided no additional result. Out of the 2185 ab-
stracts screened after duplicates removal, 1859 were ex-
cluded, most because they were unrelated to the topic 
(84.6%) or not reporting original data (10.0%). A total of 
326 full-text articles were assessed for eligibility and 260 
of them excluded (43.1% for replicated data), resulting 
in 66 potentially relevant articles. Those reporting only 
prevalence findings were singled out and examined sep-
arately [15]. Ultimately, 6 independent studies met the 
full inclusion criteria and provided pertinent population-
based information on the incidence of frailty.
Description of retrieved studies
The main characteristics and findings of the six pa-
pers selected are summarized in Table 1. 
Half of the studies were carried out in Europe. These 
three papers presented incidence data but their main 
goal was to explore the prospective association between 
the onset of frailty and: adherence to the Mediterra-
nean diet (MD) [20], midlife overweight and obesity 
[21], serum levels of vitamin D [22]. The three non-
European studies were specifically aimed at estimating 
and examining characteristics of the incidence of frailty 
in the population. Two of them, conducted in Texas 
(USA) [23] and Australia [24], investigated particular 
ethnic groups, providing an insight into the complex re-
lationship between frailty incidence and socio-econom-
ic factors. The remaining study examined a large sample 
of Chinese population [25]. 
All the selected studies were community-based and 
had a prospective design. Participants with frailty at 
baseline were excluded from the follow-up sample, in 
order to measure the occurrence of new cases in the 
population at risk of developing frailty during the speci-
fied period. The mean follow-up length (range 1-22.2 
years; median 5.1 years), the sample size (range 74-
6306 individuals), and the age of participants (range ≥ 
30-65 years) varied greatly across studies.
Assessment of methodological quality
The critical assessment performed according to JBI 
criteria showed a satisfactory level of methodological 
quality, with all selected papers receiving a positive ap-
praisal of at least 5 of the 9 evaluated aspects. The most 
critical issue identified was the analytical approach and 
statistical method used to measure frailty incidence. 
Five of the studies presented results in terms of inci-
dence proportions, or cumulative incidence (percent-
age of new cases on the population at risk over the 
investigated period), and one as absolute number of 
incident cases [20]. None of the papers provided an es-
timate of the incidence rate, or person-time rate (ratio 
of the number of new cases to the total time each per-
son in the population is at risk of developing the condi-
tion). This methodological weakness was accompanied 
by an overall lack of specific analysis by age, sex, and 
other relevant risk conditions and possible predictors of 
frailty. 
Incidence of frailty
Four studies [20-23] adopted slightly modified ver-
sions of the Cardiovascular Health Study (CHS) phe-
notype criteria to classify frailty [9]. The remaining two 
studies, both non-European [24, 25], were based on 
the deficits accumulation method [26, 27] and used a 
Frailty Index (FI) with 20 and 34 items, respectively. In 
addition to the two studies adopting a FI, incidence was 
estimated using the dichotomous variable (robust/frail) 
also in other two of the studies using the CHS criteria 
[20, 23]. The articles applying the trichotomous CHS 
classification (robust/pre-frail/frail) reported an inci-
dence proportion of pre-frailty that varied from 21.2% 
[22] to 36% [21]; the first result was obtained on older 
subjects (≥ 65 years) observed for about 3 years, the 
second on adults (≥ 30 years)  followed for a longer pe-
riod (mean 22.2 years). 
As shown in Table 1, results for incidence varied sub-
stantially across studies, reflecting the degree of hetero-
geneity of objectives, follow-up duration, classification 
instruments and sample characteristics. The relevance 
of this heterogeneity appeared intensified by the inci-
dence measure adopted, since incidence proportion 
is highly influenced by the time of observation and it 
steadily increases in relation to length of follow-up. This 
might account for the rather high cumulative incidence 
of frailty (5%) found in a Finnish sample of relatively 
young people (mean age 43.6 years) followed over a pe-
riod of about 22 years [21], the longest follow-up dura-
tion documented in our literature search. 
The Chinese article [25] was the only one that pre-
sented both crude (13.0%; 95% CI 12.2-13.9) and stan-
dardized incidence results (10.8%; 95% CI 10.0-11.6), 
properly accompanied by the relative 95% Confidence 
Intervals (CI). Moreover, this paper provided sex-specif-
ic results and identified subgroups of subjects at greater 
risk of developing frailty over time. A higher probability 
with increasing age, female sex, urban residence, lower 
education, presence of ≥ 3 diseases, and assumption of ≥ 
4 medications per day was reported [25]. As pointed out 
by the authors, their 1-year incidence result was slightly 
higher than in previous studies based on the Fried mod-
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Table 1
Characteristics of the studies included in the systematic review of the literature on frailty incidence
Author(s) 
Year
Country Study name Setting Number of 
participants 
Age 
(years)
Women 
(%)
Follow up 
length
mean ± SD
Frailty 
definition
Frailty 
Incidence
Other relevant 
results
EUROPEAN STUDIES
León-
Muñoz et 
al. 2014 
[20]
Spain Seniors-
ENRICA
Community 1815 ≥ 60 y
Unavailable
3.5 y CHS Frailty 7.5% * Increasing 
adherence to 
Mediterranean diet 
was associated with 
decreasing risk of 
frailty.
Stenholm 
et al. 2014 
[21]
Finland Mini-Finland 
Health 
Examination 
Survey
Community 1119 ≥ 30 y
43.6 ± 9.7 
W 58%
22.2 ± 0.82 y CHS Prefrailty 36%
Frailty 5%
Evidence that 
development of 
frailty may start 
in midlife. Being 
overweight or obese 
at baseline increased 
the risk of pre-frailty 
and frailty at follow-
up, after adjusting 
for age, sex, lifestyle 
factors and chronic 
conditions.
Vogt et al. 
2015 [22]
Germany KORA-Age 
Study
Community 727 ≥ 65 y
W 49.1% of 
tot. sample 
(954)
2.9 ± 0.1 y CHS Prefrailty 21.2% 
Frailty 3.9%
After multivariable 
adjustment, 
participants with 
very low 25(OH)
D levels had a 
significantly higher 
odds for pre-frailty 
and pre-frailty/frailty 
combined (not 
significant for frailty 
alone).
NON-EUROPEAN STUDIES
Espinoza 
et al. 2010 
[23]
Texas 
USA
San Antonio 
Longitudinal 
Study of 
Aging 
(SALSA) 
+ Oldest 
group of 
San Antonio 
Heart Study 
(SAHS) cohort
Community 606
(301 MAs; 
305 EAs)
≥ 65 y
W 57.9% 
9.9 y
(range 7.4-
12.5 y) **
CHS Frailty 7.8% 
(6.6% MA; 
8.9 EA)
After covariate 
adjustment, frailty 
incidence was 60% 
lower in MAs than 
in similarly aged EAs 
(Hispanic Paradox). 
High education 
and income 
were significantly 
associated with 
lower incident frailty. 
Men seemed more 
likely to become frail 
(not significant).
Hyde et al. 
2016 [24]
Australia / Community 74
(aboriginal 
people)
≥ 45 y
60.7 ± 11.9 
W 54.5%
6.7 ± 0.7 y FI Frailty 51.4% Very high incidence 
of frailty and 
disability at a much 
younger age than 
observed in the 
general population. 
Frailty was a strong 
predictor of all-cause 
mortality, but not 
disability.
Zheng 
et al. 
2016 [25]
China Beijin 
Longitudinal 
Study of 
Aging II 
(BLSA-II)
Community 6306 ≥ 55 y
70.5 ± 7.8
W 61.3% of 
tot. sample 
(10039)
1 y (median 
12.7 
months)
FI Frailty 13.0% 
(age- and 
sex-standard. 
10.8%)
A significant 
increasing trend 
of incidence with 
increasing age was 
found. Subgroups 
at high risk of 
developing frailty 
were women, urban 
residents, older 
adults, less educated 
subjects, and those 
with comorbidities 
or polypharmacy.
CHS = Cardiovascular Health Study; FI = Frailty Index; MAs = Mexican Americans; EAs = European Americans.
* No incidence rate or proportion provided; percentages in the Table based on reported number of incident cases (137). 
** Three follow-up examinations between 2000 and 2005, 18 months apart. Incident cases at previous follow-up were not excluded from the 2nd and 3rd waves. For 
this reason, only frailty incidence at the end of follow-up period (mean 9.9 years), estimated on non-frail at baseline, is presented in the Table.
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el. This might be attributable to the characteristics of the 
FI that takes into account not only physical frailty but 
also cognitive impairment, depression, and comorbidity 
and is a more sensitive instrument. 
However, the high variability of results was also evi-
dent in studies that shared the same definition of frailty 
(CHS) and were conducted on relatively similar sam-
ples in terms of age (≥ 60-65). The reported incidence 
proportions ranged from 3.9% for a follow-up of about 
3 years [22] to about 8% over periods from 3.5 [20], to 
9.9 years [23].
The 7-year frailty incidence registered among Austra-
lian aboriginal people aged 45 years and over is clearly 
an outlier [24]. The extraordinarily high probability of 
developing frailty (51.5%) found in this sample is at-
tributable to the peculiar features of this indigenous 
population, characterized by the presence of deficits in 
almost all areas of health, poor life styles and psycho-
social stressors. This result, based on a FI, is particu-
larly interesting because it supports the hypothesis of 
a multifactorial aetiology of frailty, likely resulting from 
accumulated insults to the body, together with other 
external factors. 
Not taking into account the extreme outlier present-
ed in the Australian study [24], the incidence propor-
tions found in our systematic review ranged from 5% 
[21] to 13% [25], with very different follow-up times 
and participants’ ages.
DISCUSSION
This systematic review shows an overall paucity 
of data on the incidence of frailty. The few incidence 
studies available showed a considerable heterogeneity 
of findings and a substantial lack of analysis of those 
factors, such as the basic socio-demographic character-
istics, potentially influencing the development of new 
cases of frailty. The adoption of incidence proportions 
(or cumulative incidence), rather than incidence rates, 
highly influenced by the duration of follow-up, is a fur-
ther obstacle to the comparability of results. 
We know that frailty is very common among older 
people, roughly affecting about 10% of the popula-
tion over 65 years of age [28], increases with age, is 
higher in women than men, is associated with lower 
education and income, poorer health, higher rates of 
comorbid chronic conditions and disability [9]. In-
creasing evidence of an association between frailty, 
cognitive impairment and dementia is emerging [3, 
29]. A north-south gradient has also been suggested, 
with a higher prevalence in southern than in northern 
European countries [30]. All these findings – underlin-
ing the importance of integrating socioeconomic fac-
tors when studying the epidemiology of frailty – are 
based on cross-sectional, prevalence studies; while 
only two studies [23, 25] from the present systematic 
review reported incidence proportions specific by sex 
and other possible risk or protective factors. It might 
be argued that the associations observed by means 
of cross-sectional studies could be the same as those 
found through longitudinal studies, but this is not ex-
actly correct. Incidence deals with the transition from 
health to disease, whereas prevalence focuses on the 
period of time that a person lives with a disease. From 
an analytic point of view, cross-sectional studies are 
weaker than cohort or prospective studies because 
they usually cannot disentangle risk factors associated 
with the occurrence of a disease/condition (incidence) 
from those related to the survival with that disease/
condition [31]. This distinction is pivotal to provide a 
useful and reliable scientific base of knowledge to in-
form and prioritize cost-effective services, treatments 
and interventions, and is even more relevant for con-
ditions, such as frailty, with a fluctuating nature over 
time.
The difficulty in comparing results, due to the great 
variability of follow-up lengths and sample characteris-
tics across studies, might also be affected by the adop-
tion of incidence proportions rather than incidence 
rates as measure of the frequency of frailty. In contrast 
with incidence rate (or person-time rate), which put 
the disease/condition in the perspective of the size of 
the population and incorporates time directly into the 
denominator, incidence proportion (or cumulative inci-
dence) takes the perspective of what happens over an 
accumulation of time. As a consequence, the cumula-
tive incidence increases each year as the cases continue 
to accumulate but the denominator, composed of the 
initial population at risk, remains fixed, thus limiting 
the comparability of findings, especially in case of great 
variability of follow-up durations. Incidence rates de-
scribe how quickly a disease occurs in a population and 
are the best instrument to evaluate the effectiveness of 
prevention programmes. However, although the use of 
cumulative incidence may be considered a methodolog-
ical weakness, it is necessary to take into account that 
it is very often used because it is easier to calculate and 
understand. The adoption of incidence proportion can 
be plausible in studies not having incidence estimates 
as their main goal, like the majority of those identified 
through the present systematic review. 
From a public health perspective, the scarce and rather 
unequal data available on the occurrence of frailty over 
time reduce the possibility of drawing a conclusion about 
the number of new cases we can reasonably expect in 
the future. In addition, the substantial lack of in-depth 
prospective analyses including predictors and risk factors 
involved in frailty development and progression prevents 
from reaching the clear and unambiguous base of knowl-
edge that is essential to plan a responsive health care sys-
tem focused on the actual needs of older subjects.
CONCLUSIONS
Well-designed and methodologically sound prospec-
tive studies of frailty are necessary to overcome the 
overall paucity of data regarding the occurrence and 
progression of this dynamic condition over time. To fa-
cilitate comparison of frailty incidence in different loca-
tions, at different times or among different groups of 
persons from potentially different populations, it should 
be estimated in terms of incidence rate (or person-time 
rate), instead of incident proportion (or cumulative in-
cidence). A careful longitudinal investigation of major 
health and socioeconomic factors potentially involved 
in the development of new cases, and in the progression 
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of existing ones, is of utmost importance to understand 
the underlying causes of frailty in the population, and 
if possible, reverse it. Large-scale and up-to-date pop-
ulation-based studies of frailty incidence are urgently 
needed to inform resource planning and the prioriti-
zation of interventions to overcome the current inad-
equacy of health care systems to meet the multiple and 
complex needs of frail older people. 
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